Publisher： Bentham Science Publishers
E-ISSN： 1873-5592|11|2|179-186
ISSN： 1389-4501
Source： Current Drug Targets, Vol.11, Iss.2, 2010-02, pp. : 179-186
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
No increased cancer risk with immunosuppressants in IBD
Reactions Weekly, Vol. 1, Iss. 1138, 2007-01 ,pp. :
Access to resources
Recommend
How to Manage the Infectious Risk under Anti-TNF in Inflammatory Bowel Disease
Current Drug Targets, Vol. 11, Iss. 2, 2010-02 ,pp. :
Anti - TNF Therapy for Crohn's Disease
Current Pharmaceutical Design, Vol. 9, Iss. 4, 2003-02 ,pp. :
Azathioprine and mercaptopurine: increased lymphoma risk
Inpharma, Vol. 1, Iss. 1507, 2005-01 ,pp. :
Warning: anti-TNF therapy might cause tuberculosis
By O'Neill L.
Trends in Pharmacological Sciences, Vol. 23, Iss. 1, 2002-01 ,pp. :